SCHEMBL8323210

SCHEMBL8323210

COc1ccc(C2NC(C(=O)O)Cc3c2[nH]c2ccccc32)cc1O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.85
KMT2A Q03164 4/20 0.85
ALDH1A1 P00352 3/20 0.85
ALOX12 P18054 1/20 0.85
KDM4E B2RXH2 5/20 0.76
CYP2D6 P10635 2/20 0.76
CYP2C19 P33261 1/20 0.76
SMN1; SMN2 Q16637 1/20 0.76
TSHR P16473 1/20 0.67
MAPK1 P28482 1/20 0.67
ALOX15 P16050 1/20 0.63
HSD17B10 Q99714 1/20 0.63
MAPT P10636 2/20 0.61
PDE5A O76074 1/20 0.59
CCKBR P32239 2/20 0.58
HDAC1 Q13547 2/20 0.57
HDAC6 Q9UBN7 2/20 0.57
HPGD P15428 1/20 0.54
ACHE P22303 1/20 0.53
PRMT5 O14744 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17444753 1.00 MEN1 (0.85) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL8323002 0.92 MEN1 (1.00) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL17760542 0.92 MEN1 (1.00) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL1921539 0.91 PDE5A (0.72) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL1921584 0.89 MEN1 (0.83) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL16067304 0.89 KDM4E (0.84) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL8320596 0.87 MEN1 (0.87) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL21993755 0.87 CYP2D6 (0.76) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL8316124 0.86 KDM4E (1.00) MEN1KMT2AALDH1A1ALOX12KDM4E
SCHEMBL3425302 0.86 MEN1 (0.79) MEN1KMT2AALDH1A1ALOX12KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004113336-A1 CARBOLINE AND BETACARBOLINE DERIVATIVES FOR USE AS HDAC ENZYME INHIBITORS CHROMA THERAPEUTICS LIMITED (GB) 2004-12-29 WO disclosed